Moderna Inc (MRNA)
128.52
+0.81
(+0.63%)
USD |
NASDAQ |
Jun 01, 16:00
129.59
+1.07
(+0.83%)
After-Hours: 05:04
Moderna PS Ratio: 3.573 for June 1, 2023
PS Ratio Chart
Historical PS Ratio Data
| Date | Value |
|---|---|
| June 01, 2023 | 3.573 |
| May 31, 2023 | 3.551 |
| May 30, 2023 | 3.584 |
| May 26, 2023 | 3.51 |
| May 25, 2023 | 3.516 |
| May 24, 2023 | 3.659 |
| May 23, 2023 | 3.83 |
| May 22, 2023 | 3.524 |
| May 19, 2023 | 3.51 |
| May 18, 2023 | 3.485 |
| May 17, 2023 | 3.491 |
| May 16, 2023 | 3.479 |
| May 15, 2023 | 3.622 |
| May 12, 2023 | 3.595 |
| May 11, 2023 | 3.570 |
| May 10, 2023 | 3.638 |
| May 09, 2023 | 3.719 |
| May 08, 2023 | 3.663 |
| May 05, 2023 | 3.810 |
| May 04, 2023 | 3.735 |
| May 03, 2023 | 3.618 |
| May 02, 2023 | 3.654 |
| May 01, 2023 | 3.709 |
| April 28, 2023 | 3.695 |
| April 27, 2023 | 3.616 |
| Date | Value |
|---|---|
| April 26, 2023 | 3.635 |
| April 25, 2023 | 3.751 |
| April 24, 2023 | 3.841 |
| April 21, 2023 | 3.916 |
| April 20, 2023 | 3.924 |
| April 19, 2023 | 3.971 |
| April 18, 2023 | 3.966 |
| April 17, 2023 | 4.003 |
| April 14, 2023 | 4.368 |
| April 13, 2023 | 4.463 |
| April 12, 2023 | 4.325 |
| April 11, 2023 | 4.317 |
| April 10, 2023 | 4.453 |
| April 06, 2023 | 4.401 |
| April 05, 2023 | 4.299 |
| April 04, 2023 | 4.352 |
| April 03, 2023 | 4.434 |
| March 31, 2023 | 4.270 |
| March 30, 2023 | 3.250 |
| March 29, 2023 | 3.280 |
| March 28, 2023 | 3.238 |
| March 27, 2023 | 3.270 |
| March 24, 2023 | 3.325 |
| March 23, 2023 | 3.293 |
| March 22, 2023 | 3.266 |
Price to Sales Ratio Definition
The Price to Sales Ratio (PS Ratio) is calculated by taking the stock price / revenue per share (ttm). This metric is considered a valuation metric that confirms whether the sales of a company justifies the stock price. There isn't necesarily an optimum PS ratio, since different industries will have different ranges of PS Ratios. Because of this, PS Ratio is great to evaluate from a relative standpoint with other similar companies. PS Ratio might also be a handy metric for companies that are not profitable yet, since they might be valued moreso by their overall sales and potential of becoming profitable in the future.
PS Ratio Range, Past 5 Years
2.265
Minimum
Sep 29 2022
1119.99
Maximum
Dec 08 2020
128.09
Average
43.68
Median
Jun 07 2021
PS Ratio Benchmarks
| Johnson & Johnson | 4.249 |
| Merck & Co Inc | 4.879 |
| Pfizer Inc | 2.342 |
| Eli Lilly and Co | 14.25 |
| Regeneron Pharmaceuticals Inc | 6.722 |
PS Ratio Related Metrics
| PE Ratio | 11.11 |
| Price to Book Value | 2.597 |
| Price to Free Cash Flow | 86.26 |
| Price | 128.52 |
| Earnings Yield | 9.00% |
| Market Cap | 48.99B |
| Operating PE Ratio | 10.94 |
| Normalized PE Ratio | 11.03 |